SAN CLEMENTE, Calif., Nov. 7, 2022 (GLOBE NEWSWIRE) — ReShape Lifesciences Inc. RSLS, The leading physician-led weight loss and metabolic health solutions company announced today that it will release its financial results for the third quarter ended September 30, 2022, including a company update, on Monday, November 14, 2022, ahead of the launch.
Management will hold a conference call on November 14 at 8:00 am ET. A live webcast will be available in the Events and Presentations section of ReShape’s website at: https://ir.reshapelifesciences.com/events-and-presentations. To access the call by phone, please register as follows registration link, and dial-in details are provided. Participants using this feature are asked to dial into the conference call 15 minutes in advance to avoid delays.
An archived rendition will also be available in the Events and Presentations section of ReShape’s website at: https://ir.reshapelifesciences.com/events-and-presentations.
About ReShape Lifesciences™
ReShape Lifesciences™ is America’s leading weight loss and metabolic health solutions company, offering an integrated portfolio of proven products and services to treat and manage obesity and metabolic diseases. The FDA-cleared Lap-Band® program offers a minimally invasive, long-term treatment for obesity and is an alternative to more invasive surgical stapling procedures such as gastric bypass or gastric sleeve removal. reshapeCare™ is a virtual weight management…
